InvestorsHub Logo
Followers 22
Posts 3372
Boards Moderated 0
Alias Born 04/01/2000

Re: Anesthesia 2007 post# 3231

Sunday, 03/18/2018 11:27:09 AM

Sunday, March 18, 2018 11:27:09 AM

Post# of 4159
I like this part of Theralase's latest PR:

In the latest research, Theralase has demonstrated the ability of Rutherrin® PDT to destroy GSC-818 brain cancer stem cells in the 300 to 600 nM range, when activated by green laser light (520 nm / 20 J/cm2).

Pavel Kaspler, Ph.D., Research Scientist at Theralase stated that, “GSC-818 GBM cancer stem cells have been completely destroyed by Rutherrin® PDT at concentrations that are up to ten times lower (300 to 600 nM) than those levels detected by mass spectrometry in previously reported Theralase research for the treatment of orthotopic rat GBM tumours utilising the RG2 animal model (3 uM). Another important observation is that the destruction of these GBM brain cancer cells was completed at light doses 4.5 times less than that used for PDT in animals and clinically (20 J/cm2 versus 90 J/cm2). These important discoveries are allowing our team to optimize GBM treatments preclinically to allow translation of this technology to a Phase Ib GBM clinical study using Rutherrin® PDT and our latest discovery, the cancer vaccine.”


Are they really saying that they have a cancer vaccine? I have friends, whose skin cancer on their face keeps coming back.